Baylor University Medical Center Hematopathology

Topics

• Acute Myeloid Leukemia Research 26
• Chronic Lymphocytic Leukemia Research 17
• Lymphoma Diagnosis and Treatment 17
• Viral-associated cancers and disorders 11
• Hematological disorders and diagnostics 9
• Acute Lymphoblastic Leukemia research 5
• Chronic Myeloid Leukemia Treatments 4
• Multiple Myeloma Research and Treatments 4
• Vascular Tumors and Angiosarcomas 4
• Amyloidosis: Diagnosis, Treatment, Outcomes 3
• Bacterial Identification and Susceptibility Testing 3
• Myeloproliferative Neoplasms: Diagnosis and Treatment 3

Most cited

1. Impact of early relapse within 24 months after first-line systemic therapy (POD24) on outcomes in patients with marginal zone lymphoma: A US multisite study.

   Journal of hematology & oncology · 2023 · 20 citations · Kathryn Lindsey

2. Noncanonical activation of GLI signaling in SOX2+ cells drives medulloblastoma relapse.

   Science advances · 2022 · 16 citations · Kathryn Lindsey

3. Myeloid sarcoma diagnosed on pleural effusion cytology: A case report and literature review.

   Diagnostic cytopathology · 2021 · 5 citations · Kathryn Lindsey

4. Primary Malignant Melanoma of the Lung (PMML); A Case Report.

   Cureus · 2023 · 3 citations · Robbie Graham

5. Postibrutinib relapse outcomes for patients with marginal zone lymphoma.

   Blood advances · 2023 · 5 citations · Kathryn Lindsey

6. Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study.

   Journal of hematology & oncology · 2022 · 7 citations · Kathryn Lindsey

7. Standard-Dose Rituximab as Effective Therapy for Treating Malignancy-Related Hemophagocytic Lymphohistiocytosis in the Eldery: A Case Report.